BioCentury
ARTICLE | Distillery Techniques

Drug delivery

November 15, 2016 5:43 PM UTC

An HDL-mimicking nanoparticle could safely deliver atherosclerosis therapies to the liver. In vitro assays and in vivo testing of a library of HDL- mimicking nanoparticles identified one nanoparticle ...

BCIQ Target Profiles

Liver X receptor (LXR)